- Home
- ENGN vs GDEV Comparison
ENGN vs GDEV Comparison
Compare ENGN & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENGN
- GDEV
- Stock Information
- Founded
- ENGN 1999
- GDEV 2009
- Country
- ENGN Canada
- GDEV Cyprus
- Employees
- ENGN N/A
- GDEV N/A
- Industry
- ENGN
- GDEV EDP Services
- Sector
- ENGN
- GDEV Technology
- Exchange
- ENGN Nasdaq
- GDEV Nasdaq
- Market Cap
- ENGN 297.7M
- GDEV N/A
- IPO Year
- ENGN N/A
- GDEV N/A
- Fundamental
- Price
- ENGN $3.39
- GDEV $15.45
- Analyst Decision
- ENGN Buy
- GDEV Buy
- Analyst Count
- ENGN 7
- GDEV 2
- Target Price
- ENGN $23.29
- GDEV $70.00
- AVG Volume (30 Days)
- ENGN 54.9K
- GDEV 37.4K
- Earning Date
- ENGN 06-13-2025
- GDEV 05-27-2025
- Dividend Yield
- ENGN N/A
- GDEV N/A
- EPS Growth
- ENGN N/A
- GDEV N/A
- EPS
- ENGN N/A
- GDEV 1.38
- Revenue
- ENGN N/A
- GDEV $420,933,000.00
- Revenue This Year
- ENGN N/A
- GDEV $4.73
- Revenue Next Year
- ENGN N/A
- GDEV $16.15
- P/E Ratio
- ENGN N/A
- GDEV $11.17
- Revenue Growth
- ENGN N/A
- GDEV N/A
- 52 Week Low
- ENGN $3.27
- GDEV $8.60
- 52 Week High
- ENGN $14.67
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- ENGN 27.30
- GDEV 62.08
- Support Level
- ENGN $3.51
- GDEV $10.25
- Resistance Level
- ENGN $3.99
- GDEV $18.33
- Average True Range (ATR)
- ENGN 0.40
- GDEV 1.43
- MACD
- ENGN -0.00
- GDEV 0.79
- Stochastic Oscillator
- ENGN 10.71
- GDEV 64.36
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.